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Sir: With interest we read Mackenzie
and Woodhouse’s paper about serum
C-reactive protein (CRP) levels in
patients with and without liver dys-
function during bacteraemia [1]. The
authors concluded that patients with
biochemical evidence of liver disease
show signiﬁcantly lower serum CRP
levels during bacteraemia than pa-
tients without liver dysfunction. This
remarkable result was only achieved
when patients with biopsy-proven
liver cirrhosis were included in the
analysis. When cirrhotic patients
were excluded, however, and patients
with liver dysfunction, deﬁned as an
elevated plasma bilirubin level and
increased prothrombin time, were
compared with controls, between-
group differences did not reach
statistical signiﬁcance. Therefore,
we feel that from the available data
it cannot be concluded that patients
with liver diseases, in general, gen-
erate lower serum CRP levels during
bacteraemia.
As multiple studies have shown
greater CRP production in cirrhotic
non-infected patients than in healthy
controls [2, 3], it could be argued
that cirrhotic patients produce less
CRP during periods of infection.
However, a recent large study in crit-
ically ill subjects reported that CRP
levels during infection in cirrhotic
patients did not signiﬁcantly differ
from CRP levels in non-cirrhotic
patients [4]. Also, no differences were
found in relation to the severity of
the cirrhosis. Because interleukin-6
stimulates hepatocytes to produce
CRP, an interesting study to aid the
understanding of these apparently
conﬂicting results would be to re-
late the interleukin-6 to CRP levels
in cirrhotic patients. However, as
far as we know, this has not been
done.
Finally, we believe that the use
of CRP as a valuable screening test
for infection in the ICU has certain
limitations. The decision on starting
antibiotics must be individualized
and not be based on a certain CRP
level. It should be based on suspicion
of the presence of infection, the
stability of the patient’s clinical con-
dition, the presence of comorbidity
and the risk of death or compli-
cations.
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